Skip to main content


Can we cure ATL: new drugs and targeting ATL stem cells

Article metrics

  • 678 Accesses

No abstract submitted

Author information

Correspondence to Olivier Hermine.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article


  • Stem Cell
  • Infectious Disease
  • Cancer Research